| Symbol |
Name |
|
AIRE
|
autoimmune regulator
|
|
ALS2CR12
|
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12
|
|
ANXA9
|
annexin A9
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
ASIP
|
agouti signaling protein
|
|
ATM
|
ATM serine/threonine kinase
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CD28
|
CD28 molecule
|
|
CDA
|
cytidine deaminase
|
|
CDK10
|
cyclin-dependent kinase 10
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CLPTM1L
|
CLPTM1-like
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
EDNRB
|
endothelin receptor type B
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMOX1
|
heme oxygenase 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IRF4
|
interferon regulatory factor 4
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
MAGEA1
|
melanoma antigen family A1
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAGEC1
|
melanoma antigen family C1
|
|
MAGEC2
|
melanoma antigen family C2
|
|
MAGEE1
|
melanoma antigen family E1
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MLH1
|
mutL homolog 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MSH2
|
mutS homolog 2
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MX2
|
MX dynamin-like GTPase 2
|
|
NBN
|
nibrin
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
OCA2
|
oculocutaneous albinism II
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PIGU
|
phosphatidylinositol glycan anchor biosynthesis, class U
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PMEL
|
premelanosome protein
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POMC
|
proopiomelanocortin
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
SHROOM3
|
shroom family member 3
|
|
SLC24A4
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 4
|
|
SLC45A2
|
solute carrier family 45, member 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TP53
|
tumor protein p53
|
|
TYR
|
tyrosinase
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
